Icu Medical (ICUI) Cash & Equivalents (2009 - 2026)

Icu Medical (ICUI) has reported Cash & Equivalents for 18 consecutive years, with $298.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents fell 0.58% year-over-year to $298.3 million; the trailing twelve-month figure through Jun 2026 stood at $298.3 million (down 0.58% YoY), and the FY2025 full-year result was $308.0 million, changed 0.2% from the prior year.
• Cash & Equivalents advanced to $298.3 million in Q2 2026 per ICUI's latest filing, from $288.3 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $329.4 million in Q1 2022 and bottomed at $195.9 million in Q2 2023.
• Historically, Cash & Equivalents has averaged $270.3 million across 5 years, with a median of $289.0 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents tumbled 62.23% in 2022, then jumped 58.48% in 2024.
• Over 5 years, Cash & Equivalents stood at $208.8 million in 2022, then increased by 21.76% to $254.2 million in 2023, then gained by 21.38% to $308.6 million in 2024, then decreased by 0.2% to $308.0 million in 2025, then slipped by 3.14% to $298.3 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $298.3 million, $288.3 million, and $308.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.